CRISPR Therapeutics analysis: long-term upside despite volatility. Track Casgevy ramp, pipeline milestones & cash runway.

To meet the federal target of 82% renewable electricity by 2030, the Clean Energy Council continues to estimate that ...

Within the AI landscape, quantum computing stocks were some of the biggest winners. In particular, growth investors have taken a liking to smaller developers over the usual suspects in big tech. For ...

C-reactive protein (CRP) is a key inflammation marker that can predict heart attack and stroke risk—often better than LDL ...

An Instagram post about the last two northern white rhinos references a scenario conservationists have warned us about for decades. Saving this species may now be an impossibility. The only living ...

Every time our body encounters a new disease-causing agent, a crucial defense system called adaptive immunity comes into play ...

Georgetown University's Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, ...

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...

Wang also acknowledges emerging platforms such as CAR NK cells and in vivo CAR T technologies but notes these remain ...